J D LLOYD-STILL
Overview
Explore the profile of J D LLOYD-STILL including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
376
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
LLOYD-STILL J, Beno D, Uhing M, Kimura R
J Pediatr Gastroenterol Nutr
. 2001 May;
32(3):270-3.
PMID: 11345174
Background: The objective of the study was to determine whether ursodeoxycholic acid (Ursodiol) is protective against ibuprofen (IBU)-induced enteropathy. Methods: Using the chronically catheterized rat model, IBU (60 mg/kg body...
2.
LLOYD-STILL J, Beno D, Kimura R
Curr Gastroenterol Rep
. 2000 Sep;
1(3):231-7.
PMID: 10980955
An epidemic of fibrosing colonopathy, a new disease caused by the prolonged administration of excessive doses of pancreatic enzymes, was first reported in 1994. More than 60 cases were known...
3.
Kimura R, Dy S, Uhing M, Beno D, Jiyamapa V, LLOYD-STILL J
J Pediatr Gastroenterol Nutr
. 1999 Aug;
29(2):178-83.
PMID: 10435655
Background: High-dose ibuprofen therapy limits the progression of lung disease in patients with cystic fibrosis. However, ibuprofen increases intestinal permeability, which potentiates intestinal damage caused by high-dose pancreatic enzyme treatment,...
4.
LLOYD-STILL J, Beno D, Uhing M, Kimura R
Lancet
. 1999 Jul;
354(9174):251.
PMID: 10421325
No abstract available.
5.
LLOYD-STILL J, Uhing M, Arango V, Fusaro A, Kimura R
J Pediatr Gastroenterol Nutr
. 1998 May;
26(5):489-95.
PMID: 9586757
Background: Fibrosing colonopathy in cystic fibrosis occurs in children 2 to 7 years old and is associated with excess doses of high and regular strength lipase pancreatic enzymes, given for...
6.
FitzSimmons S, Burkhart G, Borowitz D, Grand R, Hammerstrom T, Durie P, et al.
N Engl J Med
. 1997 May;
336(18):1283-9.
PMID: 9113931
Background: Fibrosing colonopathy has been reported in young children with cystic fibrosis, the majority of whom take high-strength pancreatic-enzyme supplements to control intestinal malabsorption. We conducted a case-control study in...
7.
LLOYD-STILL J, Listernick R
J Pediatr
. 1997 Mar;
130(3):503-4.
PMID: 9063438
No abstract available.
8.
LLOYD-STILL J, Bibus D, Powers C, Johnson S, Holman R
Acta Paediatr
. 1996 Dec;
85(12):1426-32.
PMID: 9001653
Unlabelled: Essential fatty acid (EFA) deficiency is a predisposing factor for pulmonary infection with Staphylococcus aureus and Pseudomonas aeruginosa, the two major pathogenic microorganisms in cystic fibrosis (CF). Objective: The...
9.
LLOYD-STILL J
J Pediatr Gastroenterol Nutr
. 1996 Dec;
23(5):583-5.
PMID: 8985849
No abstract available.
10.
Powers C, Potter E, WESSEL H, LLOYD-STILL J
Arch Pediatr Adolesc Med
. 1996 May;
150(5):554-5.
PMID: 8620244
No abstract available.